These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 430374)

  • 21. Antiandrogenic properties of nomegestrol acetate.
    Duc I; Botella J; Bonnet P; Fraboul F; Delansorne R; Paris J
    Arzneimittelforschung; 1995 Jan; 45(1):70-4. PubMed ID: 7893274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiandrogenic activity of pyrethroid pesticides cyfluthrin and beta-cyfluthrin.
    Zhang J; Zhu W; Zheng Y; Yang J; Zhu X
    Reprod Toxicol; 2008 Aug; 25(4):491-6. PubMed ID: 18586453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium prorenoate: a new steroidal aldosterone antagonist.
    Hofmann LM; Chinn LJ; Pedrera HA; Krupnick MI; Suleymanov OD
    J Pharmacol Exp Ther; 1975 Aug; 194(2):450-6. PubMed ID: 1151770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
    Gross ND; Kempton JB; Trune DR
    Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifentidine: evaluation of antiandrogen effects and kidney function studies.
    Francalanza G; Franco C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):456-8. PubMed ID: 2859037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
    Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.
    Sica DA
    Heart Fail Rev; 2005 Jan; 10(1):23-9. PubMed ID: 15947888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiandrogenic effect of spirolactones: mechanism of action.
    Corvol P; Michaud A; Menard J; Freifeld M; Mahoudeau J
    Endocrinology; 1975 Jul; 97(1):52-8. PubMed ID: 166833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
    Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-androgenic activity of spironolactone.
    Steelman SL; Brooks JR; Morgan ER; Patanelli DJ
    Steroids; 1969 Oct; 14(4):449-50. PubMed ID: 5344274
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative antiandrogenic potency of spironolactone and cimetidine: assessment by the chicken cockscomb topical bioassay.
    Hennessey JV; Glass AR; Barnes S; Vigersky RA
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):443-7. PubMed ID: 3737611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SC 23992: radioreceptor assays for therapeutic and side effects.
    Funder JW; Mercer J; Hood J
    Clin Sci Mol Med Suppl; 1976 Dec; 3():333s-334s. PubMed ID: 1071640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative inhibitory potency of five mineralocorticoid antagonists on aldosterone biosynthesis in vitro.
    Netchitailo P; Delarue C; Perroteau I; Leboulenger F; Capron MH; Vaudry H
    Biochem Pharmacol; 1985 Jan; 34(2):189-94. PubMed ID: 2981534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.
    Nickisch K; Bittler D; Laurent H; Losert W; Casals-Stenzel J; Nishino Y; Schillinger E; Wiechert R
    J Med Chem; 1987 Aug; 30(8):1403-9. PubMed ID: 3612688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiandrogenic effects of spironolactone: hormonal and ultrastructural studies in dogs and men.
    Baba S; Murai M; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1978 Mar; 119(3):375-80. PubMed ID: 642094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steady-state relative potency of aldosterone antagonists: spironolactone and prorenoate.
    McInnes GT; Shelton JR; Harrison IR
    Clin Pharmacol Ther; 1981 May; 29(5):679-86. PubMed ID: 7214797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiandrogen. II. Oxygenated 2-oxapregnane steroids.
    Takegawa S; Koizumi N; Takahashi H; Shibata K
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):870-5. PubMed ID: 7687931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiandrogenic effect of spirolactones: different mechanisms of action (author's transl)].
    Mahoudeau JA; Corvol P; Valcke JC; Menard J; Bricaire H
    Ann Endocrinol (Paris); 1976; 37(1):57-8. PubMed ID: 1015793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.